GENEVA, SWITZERLAND / ACCESS Newswire / December 23, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX ) (MindMaze Therapeutics or the Company), a commercial-stage company delivering evidence-based, ...

RELIEF THERAPEUTICS Holding ( ($CH:MMTX) ) has issued an update. MindMaze Therapeutics has detailed a coordinated global reimbursement strategy ...

An announcement from RELIEF THERAPEUTICS Holding ( ($CH:RLF) ) is now available. Relief Therapeutics and NeuroX have completed their business ...

The newly combined entity now operates under the name MindMaze Therapeutics Holding SA. The closing followed the signing of a definitive business combination agreement in October 2025 and subsequent ...

The biopharma network of Relief Therapeutics is crucial for marketing the neurotherapies developed by Mindmaze, according to ...

GENEVA, SWITZERLAND / / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX: MMTX ) (MindMaze Therapeutics or the Company) announced today the completion of its business combination ...

MindMaze Healthcare, a digital neurotherapeutics company, is expanding its geographical footprint to patients in Latin America, the Middle East, Spain and Switzerland through a series of new ...

Switzerland-based VR company, MindMaze received a major investment from Hinduja Group, who has valued the company at over $1 billion. This is a ten-fold increase since its previous valuation in 2012 ...

MindMaze, a neurotechnology startup, is developing a simple, low-cost approach to face-tracking called MASK—claimed to be compatible with any VR headset—that can map significantly more life-like ...

MindMaze wants to build the next-generation mind-machine interface. And today, it’s taking a step in that direction with the launch of Mask, a technology that can capture your facial expression and ...